@article{JTD23488,
author = {Elisabeth Quoix and Virginie Westeel},
title = {Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 26},
year = {2018},
keywords = {},
abstract = {Chemotherapy with a platinum-based doublet has long been the cornerstone of the treatment for advanced non-small cell lung carcinoma (NSCLC) (1). Since the early 2000s, several driver gene mutations and translocations have been discovered, giving rise to the possibilities of targeted therapies (2-4).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23488}
}